Verification study of the effect of a single intake of the test food on dry eyes and eyestrai
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000041665
- Lead Sponsor
- imeQ RD inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Not provided
1. Those who are currently receiving some types of drug (except for the drugs that are taken as needed). Cholinergic agonists and anticholinergic drugs are not allowed even for abortive use (e.g., for use in stomach medicine and treatment of hyperhidrosis). 2. Those who have some kind of eye treatment (including dry eye). 3. Those who have had eye surgery within one year of the screening test and those who are planning to have eye surgery (including LASIK surgery) during the study period 4. People with serious or progressive diseases or symptoms (such as those for which drugs are used regularly on a daily basis) 5. Those who take health foods (foods or supplements that affect the body's composition, or are intended to maintain or restore health). 6. Those who have a past and current medical history of drug or food allergy. 7. Those who are participating in or currently participating in another clinical trial within one month prior to obtaining consent. 8. Pregnant, wishing to become pregnant between the screening date and the end of the food study, and breastfeeding 9. Those who regularly take foods containing lactobacillus and who have ingested dairy products (yogurt, kefir, sour cream, cheese, fermented butter, lactic acid bacteria drinks) containing lactobacillus even once within the past 7 days. 10. Those who plan to take dairy products containing lactobacillus (yogurt, kefir, sour cream, cheese, fermented butter, lactic acid bacteria drink) from the screening date to the end of the test period. 11. People with hay fever 12. Those who the investigator has determined to be inappropriate for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tear strage Near point distance measurement
- Secondary Outcome Measures
Name Time Method Tear layer destruction time Questionnaire about eye symptoms amount of saliva